Health Condition 1: G439- Migraine, unspecified
Conditions
Interventions
Intervention1: Individualised Homoeopathic Medicine: A compelete detailed case taking and repertorisation will be done according to homoeopathic principles and patient will recieve individualised homo
Sponsors
Dr Aiswarya Mohan
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients giving informed consent. 2.Have a history of migraine as defined by the International Headache Society (IHS) International Classification of Headache Disorders II guidelines 1.1 and 1.2 (ICHD-II, Cephalgia 2006) of at least 1 year prior to enrollment, migraine onset prior to age 50, and a moderate frequency of migraine headaches 3.Have clinical laboratory test results within normal reference ranges or, if outside the normal range, judged not clinically significant by the Investigator 4.Must not be on any migraine prevention therapy, including botulinum toxin (Botox) 5.Agree not to post any personal medical data related to the study or information related to the study on any website or social media site (for example, Facebook, Twitter, et cetera) until the trial has completed.
Exclusion criteria
Exclusion criteria: 1.Current enrollment in, or discontinuation within the last 30 days from, a clinical trial involving any investigational drug or device, or concurrent enrollment in any other type of medical research judged not to be scientifically or medically compatible with this study. 2.History of chronic migraine or migraine subtypes including hemiplegic (sporadic or familial) migraine, ophthalmoplegic migraine, and basilar-type migraine. 3.History of headache (for example, cluster headache or Medication Overuse Headache [MOH]) other than migraine or tension type headache as defined by IHS ICHD-II within 12 months prior to randomization. 4.Diagnosed cases of psychiatric illness. 5.Pregnant women and lactating mothers. 6.Excessive alcohol, opiate, or barbiturate use; history of drug abuse or dependence. 7.Patients who are terminally ill, under immunosuppressive treatment or self-reported immunocompromised state. 8.Unwilling to take part and not giving consent to join the study or unable to read patient information sheet.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate which is more effective i.e., individualized homoeopathic medicine or Chionanthus virginica mother tincture in management of migraine. 2.To assess the improvement of patient in terms of frequency of attack and severity of symptoms of migraine. Timepoint: Initially at baseline and then fortnightly or monthly preferably up to one year. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To assess the improvement in quality of life by using MIDAS SCALE.Timepoint: Intially at baseline and then once in three months upto one year. | — |
Countries
India
Contacts
Public ContactDr Aiswarya Mohan
Nehru Homoeopathic Medical College And Hospital
Outcome results
None listed